The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...

Following strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation ... and future implant solutions”. The global ...

The use of a spinal cord stimulation (SCS ... examined the use of Medtronic’s Vectris SureScan device in three SMA patients with all of them able to increase their six-minute walk test (6MWT ...

Until a few years ago, being fitted with an implantable pacemaker ... of detailed medical data. As far back as seven years ago, the medical device giant Medtronic introduced pacemakers and ...

The use of a spinal cord stimulation (SCS) device has the potential to gradually ... The University of Pittsburgh School of Medicine study (NCT05430113) examined the use of Medtronic’s Vectris ...

New product offerings from Medtronic and Boston Scientific have squeezed opportunity in the market, meaning Nevro’s full-year guidance for 2025 dropped from $435-445m to $400m-$405m. Boston Scientific ...

Medtronic [MDT] is a major medical technology company ... alongside significant acquisitions such as its purchase of Nanovis’ nanotechnology for use in spinal implants, then the strength of its ...

Globus Medical will acquire Nevro in an all-cash transaction. Both company boards of directors have unanimously approved the ...

For more than 20 years, the common thread has been to exploit semiconductor technology in new ways for these very space and power-constrained implantable devices ... interfaces for applications such ...